CytoDyn Inc. Quarterly report pursuant to sections 13 or 15(d)

Stock Options and Warrants (Tables)

9 Months Ended

Feb. 28, 2013

The following table represents stock option and warrant activity as of and for the nine months ended February 28, 2013:


	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Options and warrants outstanding – May 31, 2012		10,327,664		$	1.60		3.20	$	2,308,279
Granted		9,615,633		$	1.70
Exercised		(755,000	)	$	0.25
Forfeited/expired/cancelled		(1,150,000	)	$	2.00
Options and warrants outstanding – February 28, 2013		18,038,297		$	1.68		2.02	$	1,793,958
Outstanding exercisable – February 28, 2013		16,833,232		$	1.67		1.89	$	1,793,958